PINNA, ANNALISA

PINNA, ANNALISA  

Istituto di Neuroscienze - IN -  

Mostra records
Risultati 1 - 20 di 85 (tempo di esecuzione: 0.028 secondi).
Titolo Data di pubblicazione Autore(i) File
Characterization of Nasco grape pomace-loaded nutriosomes and their neuroprotective effects in the MPTP mouse model of Parkinson's disease 1-gen-2022 Parekh P.; Serra M.; Allaw M.; Perra M.; Marongiu J.; Tolle G.; Pinna A.; Casu M.A.; Manconi M.; Caboni P.; Manzoni O.J.J.; Morelli M.
Influence of Age and Genetic Background on Ethanol Intake and Behavioral Response Following Ethanol Consumption and During Abstinence in a Model of Alcohol Abuse 1-gen-2022 Corongiu, Silvia; Dessi, Christian; Espa, Elena; Pisanu, Augusta; Pinna, Annalisa; Lecca, Daniele; Fenu, Sandro; Cadoni, Cristina
Genes implicated in familial parkinson's disease provide a dual picture of nigral dopaminergic neurodegeneration with mitochondria taking center stage 1-gen-2021 Franco, Rafael; RivasSantisteban, Rafael; Navarro, Gemma; Pinna, Annalisa; ReyesResina, Irene
Involvement of the protein ras homolog enriched in the striatum, rhes, in dopaminergic neurons' degeneration: Link to parkinson's disease 1-gen-2021 Serra, Marcello; Pinna, Annalisa; Costa, Giulia; Usiello, Alessandro; Pasqualetti, Massimo; Avallone, Luigi; Morelli, Micaela; Napolitano, Francesco
Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT<inf>1A/1B</inf> receptor agonist and A<inf>2A</inf> receptor antagonist 1-gen-2021 Pinna, Annalisa; Costa, Giulia; Serra, Marcello; Contu, Liliana; Morelli, Micaela
Gender Differences in Neurodegeneration, Neuroinflammation and Na+-Ca2+ Exchangers in the Female A53T Transgenic Mouse Model of Parkinson's Disease 1-gen-2020 Costa G.; Sisalli M.J.; Simola N.; Della Notte S.; Casu M.A.; Serra M.; Pinna A.; Feliciello A.; Annunziato L.; Scorziello A.; Morelli M.
Pharmacological interactions between adenosine A<inf>2A</inf> receptor antagonists and different neurotransmitter systems 1-gen-2020 Pinna, Annalisa; Serra, Marcello; Marongiu, Jacopo; Morelli, Micaela
Combined administration of dopaminergic and nondopaminergic drugs reverses neuroinflammation in a rat model of parkinson's disease 1-gen-2019 Costa, G.; Serra, M.; Morelli, M.; Pinna, A.
Fos expression induced by olanzapine and risperidone in the central extended amygdala 1-gen-2019 Pinna, A; Costa, G; Contu, L; Morelli, M
Lack of rhes increases mdma-induced neuroinflammation and dopamine neuron degeneration: Role of gender and age 1-gen-2019 Costa G.; Porceddu P.F.; Serra M.; Casu M.A.; Schiano V.; Napolitano F.; Pinna A.; Usiello A.; Morelli M.
Neurofarmacologia nel trattamento della Malattia di Parkinson e nuovi approcci farmacologici 1-gen-2019 Pinna, Annalisa; Morelli, Micaela
Neuroinflammation and activation of Zif-268 in dyskinetic 6-OHDA-lesioned rats is counteracted by association of a 5-HT1A/1B receptor agonist and an A(2A) receptor antagonist 1-gen-2019 Pinna, A; Costa, G; Serra, M; Morelli, M
Dopaminergic neurodegeneration in a rat model of long-term hyperglycemia: preferential degeneration of the nigrostriatal motor pathway 1-gen-2018 Renaud J.; Bassareo V.; Beaulieu J.; Pinna A.; Schlich M.; Lavoie C.; Murtas D.; Simola N.; Martinoli M.G.
NCX1 and NCX3 as potential factors contributing to neurodegeneration and neuroinflammation in the A53T transgenic mouse model of Parkinson's Disease article 1-gen-2018 Sirabella, R; Sisalli, Mj; Costa, G; Omura, K; Ianniello, G; Pinna, A; Morelli, M; Di Renzo, Gm; Annunziato, L; Scorziello, A
Rhes counteracts dopamine neuron degeneration and neuroinflammation depending on gender and age 1-gen-2018 Costa G.; Pinna A.; Porceddu P.F.; Casu M.A.; Di Maio A.; Napolitano F.; Usiello A.; Morelli M.
Role of adenosine A(2A) receptors in motor control: relevance to Parkinson's disease and dyskinesia 1-gen-2018 Pinna, A; Serra, M; Morelli, M; Simola, N
Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease 1-gen-2016 Pinna, A.; Ko, Wai Kin D; Costa, G.; Tronci, E.; Fidalgo, C.; Simola, N.; Li, Qin; Li, Qin; Tabrizi, M. A.; Bezard, E.; Carta, M.; Morelli, M.
Novel (Hetero)arylalkenyl propargylamine compounds are protective in toxin-induced models of Parkinson's disease 1-gen-2016 Baranyi, Mária; Porceddu Pier, Francesca; Gölöncsér, Flóra; Gölöncsér, Flóra; Kulcsár, Szabina; Otrokocsi, Lilla; Otrokocsi, Lilla; Kittel, Ágnes; Pinna, Annalisa; Frau, Lucia; Huleatt Paul, B; Khoo Mui, Ling; Chai Christina, L L; Chai Christina, L L; Dunkel, Petra; Mátyus, Peter; Morelli, Micaela; Morelli, Micaela; Sperlágh, Beáta
The Small GTP-Binding Protein Rhes Influences Nigrostriatal-Dependent Motor Behavior During Aging 1-gen-2016 Pinna, A; Napolitano, F; Pelosi, B; Di Maio, A; Wardas, J; Casu, Ma; Costa, G; Migliarini, S; Calabresi, P; Pasqualetti, M; Morelli, M; Usiello, A
Dual target strategy: Combining distinct non-dopaminergic treatments reduces neuronal cell loss and synergistically modulates l-DOPA-induced rotational behavior in a rodent model of Parkinson's disease 1-gen-2015 FuzzatiArmentero Marie, Therese; Cerri, Silvia; Levandis, Giovanna; Ambrosi, Giulia; Montepeloso, Elena; Antoninetti, Gianfilippo; Blandini, Fabio; Baqi, Younis; Baqi, Younis; Müller Christa, E; Volpini, Rosaria; Costa, Giulia; Simola, Nicola; Pinna, Annalisa